Blue Bell Private Wealth Management »

Gt Biopharma shares owned by Blue Bell Private Wealth Management

Quarter-by-quarter ownership of Gt Biopharma (GTBP) shares owned by Blue Bell Private Wealth Management from 13F filings

Historical chart of Blue Bell Private Wealth Management investment in Gt Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Gt Biopharma held by Blue Bell Private Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gt Biopharma by Blue Bell Private Wealth Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $23 10 2.30
2024-06-30 $28 10 2.80
2024-03-31 $44 10 4.40

More positions owned by Blue Bell Private Wealth Management

Spdr S&p 500 Etf Trust Etf (SPY)
General Amern Invs Cef (GAM)
Adams Diversified Equity Cef (ADX)
Schwab U.s. Large-cap Etf Etf (SCHX)
Schwab U.s. Broad Market Etf Etf (SCHB)
Tri Contl Corp Cef (TY)
Ishares Russell 2000 Etf Etf (IWM)
Invesco S&p 500 Equal Weight Etf Etf (RSP)
Vanguard Total Stock Market Etf Etf (VTI)
Royce Small Cap Trust Cef (RVT)
Central Secs Corp Cef (CET)
Spdr Dow Jones Industrial Average Etf Trust Etf (DIA)
High Income Secs Fd Shs Ben Int Cef (PCF)
Schwab U.s. Small-cap Etf Etf (SCHA)
Vanguard S&p 500 Etf Etf (VOO)

View all positions for Blue Bell Private Wealth Management

Top funds holding Gt Biopharma

DekaBank Deutsche Girozentrale
Geode Capital Management
Vanguard Group
Susquehanna International
Wells Fargo & Company
BlackRock
BlackRock
Tower Research Capital
Morgan Stanley
Bank of America Corporation
Advisor Group Holdings
Blue Bell Private Wealth Management
Bnp Paribas Arbitrage, Snc
Royal Bank of Canada
Jpmorgan Chase & Co

View all funds holding Gt Biopharma